Pan Wang

3.6k total citations
179 papers, 2.2k citations indexed

About

Pan Wang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Pan Wang has authored 179 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 41 papers in Oncology and 41 papers in Cancer Research. Recurrent topics in Pan Wang's work include MicroRNA in disease regulation (16 papers), Cancer-related molecular mechanisms research (13 papers) and Cancer, Hypoxia, and Metabolism (12 papers). Pan Wang is often cited by papers focused on MicroRNA in disease regulation (16 papers), Cancer-related molecular mechanisms research (13 papers) and Cancer, Hypoxia, and Metabolism (12 papers). Pan Wang collaborates with scholars based in China, United States and Australia. Pan Wang's co-authors include Nan Wu, Shuanglong Xiong, Hua Feng, Bin Liao, Wei Guo, Junwei Wang, Yibo Gao, Renda Li, Jie He and Zhenlin Yang and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Pan Wang

162 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pan Wang China 28 1.1k 660 432 287 200 179 2.2k
Xiang Huang China 24 848 0.8× 517 0.8× 372 0.9× 183 0.6× 244 1.2× 114 1.7k
Ben Wielockx Germany 30 1.2k 1.1× 1.1k 1.7× 426 1.0× 546 1.9× 245 1.2× 83 2.9k
Xuan Cheng China 26 1.5k 1.4× 531 0.8× 365 0.8× 389 1.4× 304 1.5× 89 2.6k
Ying Ni United States 25 1.2k 1.1× 434 0.7× 305 0.7× 169 0.6× 155 0.8× 114 2.1k
Yuanyuan Ma China 30 1.2k 1.1× 779 1.2× 549 1.3× 247 0.9× 136 0.7× 109 2.3k
Xiang Gu China 26 875 0.8× 410 0.6× 452 1.0× 475 1.7× 114 0.6× 63 2.0k
Weidong Xu China 23 1.1k 1.0× 308 0.5× 317 0.7× 228 0.8× 199 1.0× 102 2.4k
Fei Wu China 24 1.0k 0.9× 466 0.7× 216 0.5× 209 0.7× 138 0.7× 147 2.0k
Stephanie A. Miller United States 26 1.2k 1.1× 460 0.7× 651 1.5× 320 1.1× 156 0.8× 44 2.3k
Bing Chen China 27 2.0k 1.9× 1.2k 1.8× 470 1.1× 375 1.3× 167 0.8× 151 3.1k

Countries citing papers authored by Pan Wang

Since Specialization
Citations

This map shows the geographic impact of Pan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pan Wang more than expected).

Fields of papers citing papers by Pan Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pan Wang. The network helps show where Pan Wang may publish in the future.

Co-authorship network of co-authors of Pan Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Pan Wang. A scholar is included among the top collaborators of Pan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pan Wang. Pan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Chaoqi, Dongyu Li, Junhan Zhou, et al.. (2025). Efficacy and safety of anti-PD-1 versus anti-PD-L1 in perioperative immunotherapy: A comprehensive reanalysis of randomized controlled trials. Med. 6(8). 100669–100669. 1 indexed citations
2.
Bian, Shengtai, Huijun Ye, Pan Wang, et al.. (2025). Antibacterial hydrogel: The sniper of chronic wounds. SHILAP Revista de lepidopterología. 3(3). 10 indexed citations
3.
4.
5.
Hu, Xianwen, et al.. (2024). Multimodal imaging findings of primary liver clear cell carcinoma: a case presentation. Frontiers in Medicine. 11. 1408967–1408967. 1 indexed citations
6.
Hu, Xianwen, et al.. (2024). 18F-FDG PET/CT metabolic parameters can semi-quantitatively evaluate the nature of the heart and pericardial masses: a retrospective study. Scientific Reports. 14(1). 16316–16316. 1 indexed citations
7.
Han, Xu, Ali Zhang, Pan Wang, et al.. (2024). Pleckstrin-2 Mediates the Activation of AKT in Prostate Cancer and Is Repressed by Androgen Receptor. American Journal Of Pathology. 194(10). 1986–1996. 5 indexed citations
8.
Mai, Hai‐Qiang, Shanshan Guo, Li-Ting Liu, et al.. (2024). Neoadjuvant and adjuvant toripalimab for high-risk locoregionally advanced nasopharyngeal carcinoma: A randomized, double-blind, placebo-controlled phase 2 trial.. Journal of Clinical Oncology. 42(16_suppl). 6084–6084. 3 indexed citations
9.
Zhang, Xinning, et al.. (2024). Metastasis of ovarian dysgerminoma in a postmenopausal patient: a rare case report. Annals of Medicine and Surgery. 86(8). 4788–4792. 1 indexed citations
10.
Wang, Ren, et al.. (2023). Galaxolide and Irgacure 369 are novel environmental androgens. Chemosphere. 324. 138329–138329. 6 indexed citations
11.
Han, Xu, Yang Mei, Rama K. Mishra, et al.. (2023). Targeting pleckstrin-2/Akt signaling reduces proliferation in myeloproliferative neoplasm models. Journal of Clinical Investigation. 133(6). 11 indexed citations
12.
Hu, Xianwen, Dandan Li, Rui Wang, Pan Wang, & Jiong Cai. (2023). Comparison of the application of 18F-FDG and 68Ga-DOTATATE PET/CT in neuroendocrine tumors: A retrospective study. Medicine. 102(19). e33726–e33726. 4 indexed citations
13.
Wang, Pan, et al.. (2023). Development and Validation of Subsyndromal Delirium Prediction Model in Patients With Advanced Malignant Tumor. Cancer Nursing. 48(3). e150–e155. 2 indexed citations
14.
15.
16.
Zhang, Xianbo, Mingkun Luo, Bingjie Jiang, et al.. (2023). microRNA regulation of skin pigmentation in golden-back mutant of crucian carp from a rice-fish integrated farming system. BMC Genomics. 24(1). 70–70. 4 indexed citations
17.
Huang, Jing, et al.. (2022). Low Expression of ZNF154 is Related to Poor Prognosis in Gastric Cancer. SHILAP Revista de lepidopterología. 4 indexed citations
18.
19.
Shao, Chuan, et al.. (2022). Body mass index and glioma risk: A prospective multicenter study. Frontiers in Endocrinology. 13. 933921–933921. 7 indexed citations
20.
Sun, Yanfang, Zhi‐An Wang, Ruilian Han, et al.. (2017). Isaria cicadae conidia possess antiproliferative and inducing apoptosis properties in gynaecological carcinoma cells. Mycology: An International Journal on Fungal Biology. 8(4). 327–334. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiang Huang Breakdown of academic impact, for papers by Ben Wielockx Breakdown of academic impact, for papers by Xuan Cheng Breakdown of academic impact, for papers by Ying Ni Breakdown of academic impact, for papers by Yuanyuan Ma Breakdown of academic impact, for papers by Xiang Gu Breakdown of academic impact, for papers by Weidong Xu Breakdown of academic impact, for papers by Fei Wu Breakdown of academic impact, for papers by Stephanie A. Miller Breakdown of academic impact, for papers by Bing Chen
Rankless by CCL
2026